Our data demonstrated that the cytotoxic and caspase-3/7-inducing activities and the antitumor potency (as determined by an orthotopic breast cancer xenograft model in immunodeficient mice) of the ATF7-TRAIL and the GCN4-TRAIL constructs were roughly similar [25]. This evidence concerns the gene ATF7 and breast carcinoma.